Research progress on curcumin prodrugs

Advanced Materials Research

Volumn 554-556, Issue , 2012, Pages 1857-1860

  Zhang, Yang ^a   Qu, Xiaojing ^b   Chen, Qili ^c   Zhou, Hongli ^a  

^a JILIN INSTITUTE OF CHEMICAL TECHNOLOGY   (China)

^b Soil and Fertilizer Institute   (China)

^c Research Institute of Jilin Petrochemical Company Ltd   (China)

Author keywords

Curcumin; Prodrug; Review

Indexed keywords

AMPHIPHILICS; BIOCONJUGATES; CURCUMIN; PRODRUGS; RESEARCH PROGRESS;

AMINO ACIDS; POLYETHYLENE GLYCOLS; RESEARCH; REVIEWS; SURFACE ACTIVE AGENTS;

LOADING;

EID: 84867179867     PISSN: 10226680     EISSN: None     Source Type: Book Series    
DOI: 10.4028/www.scientific.net/AMR.554-556.1857     Document Type: Conference Paper

References (18)

1. Preetha Anand, Sherin G. Thomas, Ajaikumar B. Kunnumakkara, et al. Biological activities of curcumin and its analogues(Congeners) made by man and Mother Nature [J]. Biochemical Pharmacology, 2008, 76: 1590-1611.
2. Ruby AJ, Kuttan G, Babu KD, et al. Anti-tumour and antioxidant activity of natural curcuminoids
3. Joe B, Vilaykumar M, Lokesh BR. Biological properties of curcumin-cellular and molecular mechanisms of action [J]. Crit Rev Food Sci Nutr, 2004, 44(2): 97-111.
4. Apparao Satyam, Mumbai. Prodrug containing novel bio-cleavable linkers [P]. US 20060046967, 2006-03-02.
5. CAI Rui-hong. The synthesis and characterization of curcumin bonded with polyethylene glycol
6. Takeshita K, Okazaki S, Kansui H. Effect of cholesterol on distribution of stable, hydrophobic perchlorotriphenylmethyl triethylester radical incorporated in lecithin liposomal membranes [J]. Chem Pharm Bull, 2011, 59(5):624-628.
7. G.F. Peacock, B. Ji.C. K, Wang.D.R. Lu. Cell Culture Studies of a Carborane Cholestery Ester With Conventional and PEG Liposomes [J]. Drug Delivery, 2003, 10:29-34.
8. YU Mei-rong, LIU-Xia, XU Fan-fan, etc. Cholesterol-curcumin prodrug synthesis and preliminary research of its anti-tumor effects[C]. Symposium for Annul Conference of Zhejiang Association for Chinese Medicine, Chinese Electronic Press for Academic Journal, 2009: 55-62. In Chinese
9. Bisht S, Feldmann G, Soni S, et al. Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy [J]. Nanobiotechnol. 2007, 5:1-18.
10. Shi W, Dolai S, Rizk S. et al. Synthesis of monofunctional curcumin derivatives, clickedcurcumin dimer, and a PAMAM dendrimer curcumin conjugate for therapeutic applications
11. Safavy A, Raisch KP, Mantena S, et al. Design and development of water-soluble curcumin conjugates as potential anticancer agents [J]. J. Med. Chem. 2007, 50: 6284-6288.
12. Huadong Tang, Caitlin J Murphy, Bo Zhang, et al. Amphiphilic curcumin conjugate-forming nanoparticles as anticancer prodrug and drug carriers: in vitro and in vivo effects [J]. Nanomedicine.2010, 5(6): 855-865
13. Maeda H, Wu J, Sawa T, Matsumura Y, et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review [J]. J. Control. Release, 2000, 65: 271-284.
14. Saijo, Y., Perlaky, L., Wang, H., et al. Pharmacokinetics, tissue distribution, and stability of antisense oligodeoxynucleotide phosphorothioate ISIS 3466 in mice [J]. Oncol. Res. 1994, 6(6): 243-249.
15. Marzo, A. L., Fitzpatrick, D. R., Robinson, B. W. S., et al. Antisense Oligonucleotides Specific for Transforming Growth Factor β2 Inhibit the Growth of Malignant Mesothelioma Both in Vitro and in Vivo [J]. Cancer Res. 1997, 57:3200-3207.
16. Diaz J, Diaz MM, Pastene L. et al. Randomized clinical study of the T-Cu 380A and the Lippes Loop C, in Campinas, Brazil [J]. Contraception 1982;26:221-228.
17. Lee, E. B., Shin, K. H., Woo, W. S. Combined effects of curcumin and piperine in ameliorating benzo(a)pyrene induced DNA damage [J]. Arch. Pharmacal. Res. 1984, 7, 127.
18. Satyendra Mishra, Upma Narain, Roli Mishra, et al. Design, development and synthesis of mixed bioconjugates of piperic acid-glycine, curcumin-glycine/alanine and curcumin-glycine-piperic acid and their antibacterial and antifungal properties [J]. Bioorganic & Medicinal Chemistry 13 (2005) 1477-1486.